Elliot Maltz

Insider Reports History

Entity
Individual
Location
C/O Gelesis, Inc., 501 Boylston St., Suite 6102, Boston, Massachusetts
Signature
/s/ Elliot Maltz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elliot Maltz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALIMERA SCIENCES INC Chief Financial Officer Performance-Based Restricted Stock Units 75K $290K $3.86 Mar 11, 2024 Direct
ALIMERA SCIENCES INC Chief Financial Officer Restricted Stock Units 75K $290K $3.86 Mar 11, 2024 Direct
GELESIS HOLDINGS, INC. Chief Financial Officer Common Stock 432K May 6, 2022 Direct
GELESIS HOLDINGS, INC. Chief Financial Officer Stock Option (Right to Buy) 396K May 6, 2022 Direct
Orgenesis Inc. Chief Financial Officer Stock Option (Right to Buy) 200K Sep 4, 2023 Direct
ALIMERA SCIENCES INC Chief Financial Officer Employee Stock Option (Right to Buy) 75K Jan 2, 2024 Direct

Insider Reports Filed by Elliot Maltz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALIM ALIMERA SCIENCES INC Mar 11, 2024 2 $0 4 Mar 13, 2024 Chief Financial Officer
ALIM ALIMERA SCIENCES INC Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Financial Officer
ALIM ALIMERA SCIENCES INC Jan 2, 2024 0 $0 3 Jan 4, 2024 Chief Financial Officer
ORGS Orgenesis Inc. Sep 4, 2023 1 $116K 4 Sep 5, 2023 Chief Financial Officer
ORGS Orgenesis Inc. Sep 1, 2023 0 $0 3 Sep 5, 2023 Chief Financial Officer
GLSH GELESIS HOLDINGS, INC. May 6, 2022 4 $0 4 May 9, 2022 Chief Financial Officer
GLSH GELESIS HOLDINGS, INC. Jan 13, 2022 0 $0 3 Jan 24, 2022 CFO & Treasurer